top of page
Home
Solutions
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Communities
Primary Care Doctors
Oncologists
Patients
Investors
Primary Care Doctors
Oncologists
Patients
Investors
Knowledge Center
Publications
News & Updates
Webinars
Case Studies
Patient Stories
Publications
News & Updates
Webinars
Case Studies
Patient Stories
About Lucence
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
Mobile menu (RoW)
Close
Home
Solutions
Treatment Selection
LiquidHALLMARK®
Screening & Health Risk Assessment
CardioHemeRISK™
Treatment Selection
LiquidHALLMARK®
Screening & Health Risk Assessment
CardioHemeRISK™
Communities
Oncologists
Patients
Insurers
Investors
Oncologists
Patients
Insurers
Investors
Knowledge Center
Publications
News & Updates
Webinars
Case Studies
Publications
News & Updates
Webinars
Case Studies
Patient Stories
About Us
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
Mobile menu (US)
Portal Login
Close
Solutions
Screening & Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Menu
Close
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Menu
Close
Hereditary Risk Assessment
Lumi Series
Menu
Close
Treatment Response Monitoring
LucenceMONITOR™
Menu
Close
Treatment Selection
LiquidHALLMARK®
Menu
Close
Communities
Communities
Oncologists
Patients
Insurers
Investors
Menu
Close
Communities
Primary Care Doctors
Oncologists
Patients
Investors
Menu
Close
Knowledge Center
Knowledge Center
Publications
News & Updates
Webinars
Case Studies
Patient Stories
Menu
Close
About Us
About Us
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
Menu
Close
Menu
Close
Solutions
Screening and Health Risk Assessment
CardioHemeRISK™
Menu
Close
Treatment Selection
LiquidHALLMARK®
Menu
Close
Communities
Communities
Oncologists
Patients
Insurers
Investors
Menu
Close
Knowledge Center
Knowledge Center
Publications
News & Updates
Webinars
Case Studies
Patient Stories
Menu
Close
About Us
About Us
About Lucence
Leadership
Medical Advisory Board (Coming Soon)
Careers
Contact Us
Menu
Close
Menu
Close
Portal Login
Publications
Filter by:
Year
Conference/Journal name
Publications
29 Jun 2016
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Read More
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Publications
1 Jan 2015
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition
Read More
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition
Go
Go
1
/
8
Go
Go
Like
bottom of page